Free Trial

MBX Biosciences (MBX) Stock Price, News & Analysis

MBX Biosciences logo
$12.48 +0.15 (+1.18%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MBX Biosciences Stock (NYSE:MBX)

Key Stats

Today's Range
$11.76
$12.47
50-Day Range
$9.35
$13.66
52-Week Range
$4.81
$27.50
Volume
92,284 shs
Average Volume
258,561 shs
Market Capitalization
$416.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$37.50
Consensus Rating
Buy

Company Overview

MBX Biosciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

MBX MarketRank™: 

MBX Biosciences scored higher than 65% of companies evaluated by MarketBeat, and ranked 341st out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MBX Biosciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 6 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MBX Biosciences has only been the subject of 3 research reports in the past 90 days.

  • Read more about MBX Biosciences' stock forecast and price target.
  • Earnings Growth

    Earnings for MBX Biosciences are expected to grow in the coming year, from ($13.25) to ($2.30) per share.

  • Short Interest

    There is no current short interest data available for MBX.
  • Dividend Yield

    MBX Biosciences does not currently pay a dividend.

  • Dividend Growth

    MBX Biosciences does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for MBX.
  • News Sentiment

    MBX Biosciences has a news sentiment score of 1.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.58 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MBX Biosciences this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for MBX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, MBX Biosciences insiders have bought more of their company's stock than they have sold. Specifically, they have bought $45,312.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    52.19% of the stock of MBX Biosciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about MBX Biosciences' insider trading history.
Receive MBX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MBX Biosciences and its competitors with MarketBeat's FREE daily newsletter.

MBX Stock News Headlines

MBX Biosciences Inc Executives - Morningstar
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
MBX Biosciences Inc Chart - Morningstar
See More Headlines

MBX Stock Analysis - Frequently Asked Questions

MBX Biosciences' stock was trading at $18.43 at the beginning of 2025. Since then, MBX shares have decreased by 32.3% and is now trading at $12.4750.

MBX Biosciences, Inc. (NYSE:MBX) released its quarterly earnings data on Thursday, November, 7th. The company reported ($2.78) EPS for the quarter, missing the consensus estimate of ($2.72) by $0.06.

MBX Biosciences (MBX) raised $163 million in an IPO on Friday, September 13th 2024. The company issued 10,200,000 shares at a price of $16.00 per share.

Shares of MBX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MBX Biosciences investors own include PepsiCo (PEP), Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN) and AstraZeneca (AZN).

Company Calendar

Last Earnings
11/07/2024
Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:MBX
Previous Symbol
NYSE:MBX
Fax
N/A
Employees
36
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$37.50
High Stock Price Target
$44.00
Low Stock Price Target
$30.00
Potential Upside/Downside
+200.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$416.96 million
Optionable
N/A
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:MBX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners